Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Desvenlafaxine, Atc N06ax23 For The Period February 1st, 2026 - January 31st, 2028 (plus Extension Option 1x12 Months) 2026-06-12
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Adapalene + Benzoyl Peroxide, Atc D10ad23 For The Period February 1st, 2026 - January 31st, 2028 (plus V. Option 1x12 Months) 2026-06-12
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Everolimus, Atc L04ah02 For The Period February 1st, 2026 - January 31st, 2028 (plus Extension Option 1x12 Months) 2026-06-12
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Follitropin, Atc G03ga05 For The Period February 1st, 2026 - January 31st, 2028 2026-06-12
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Brimonidine (excl. Dafo. Edp), Atc S01ea05 For The Period 02/01/26 - 01/31/28 (plus V. Option 1x12 Months) 2026-06-12
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Brimonidine + Timolol, Atc S01ed69 For The Period February 1st, 2026 - January 31st, 2028 (plus Extension Option 1x12 Months) 2026-06-12
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Progesterone (excl. Dafo. Wka), Atc G03da04 For The Period 02/01/26 - 01/31/28 (plus V. Option 1x12 Months) 2026-06-12
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Pasireotide, Atc H01cb05 For The Period February 1, 2026 - January 31, 2028 2026-06-12
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Apremilast, Atc L04aa32 For The Period February 1st, 2026 - January 31st, 2028 (plus Extension Option 1x12 Months) 2026-06-12
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Follitropin, Atc G03ga05 For The Period February 1st, 2026 - January 31st, 2028 2026-06-12
Whats app